Format

Send to

Choose Destination
Biochemistry. 2019 Apr 16;58(15):1945-1946. doi: 10.1021/acs.biochem.9b00200. Epub 2019 Apr 3.

YTHDF1 Control of Dendritic Cell Cross-Priming as a Possible Target of Cancer Immunotherapy.

Author information

1
Department of Immunobiology , Yale School of Medicine , New Haven , Connecticut 06519 , United States.
2
Department of Molecular, Cellular, and Developmental Biology , Yale University , New Haven , Connecticut 06520 , United States.
3
Howard Hughes Medical Institute , Chevy Chase , Maryland 20815 , United States.

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center